Frontiers Production Office
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
by Murugan E and Yogaraj V (2023). Front. Chem. 11:1123775. doi: 10.3389/fchem.2023.1123775
Due to an Editorial Office error, the following declaration was missed from the Conflict of Interest statement: “The handling editor NJ declared a past collaboration with the author EM.”
The publisher apologizes for this mistake. The original version of this article has been updated.
Keywords: PAMAM dendrimer, congestive heart failure, solubility enhancement, sustained release, biocompatibility
Citation: Frontiers Production Office (2023) Erratum: Development of a quaternary ammonium poly (amidoamine) dendrimer-based drug carrier for the solubility enhancement and sustained release of furosemide. Front. Chem. 11:1236207. doi: 10.3389/fchem.2023.1236207
Received: 07 June 2023; Accepted: 07 June 2023;
Published: 13 June 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn